Evidence map›Paper›PMID 38620752›Full record

ArticleIFAC-PapersOnLine2022

Resilient Roadmap to Minimise the Impact of COVID-19 in the Spanish Enterprises.

Raquel Sanchis, Tania Cruz-Valdivieso, Giulio Marcucci, Raul Poler

Open access · diamondAbstract read
In one paragraph

Article in IFAC-PapersOnLine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Raquel SanchisResearch Centre on Production Management and Engineering (CIGIP), Universitat Politècnica de València, Calle Alarcón, n°1, Alcoy, 03801 Alicante, Spain.
Tania Cruz-ValdiviesoEscuela Politécnica Superior de Alcoy, Universitat Politècnica de València, Plaza Ferrándiz y Carbonell n° 2, Alcoy, 03801, Alicante, Spain.
Giulio MarcucciDepartment of Industrial Engineering and Mathematical Science, Università Politecnica delle Marche, Via Brecce Bianche, Ancona, 60131, Ancona, Italy.
Raul PolerResearch Centre on Production Management and Engineering (CIGIP), Universitat Politècnica de València, Calle Alarcón, n°1, Alcoy, 03801 Alicante, Spain.
Universitat Politècnica de València · ESMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

If something has failed in the management of COVID-19 crisis, this has been the lack of resilience to anticipate, adapt and recover from this event. This paper analyses the impact of COVID-19 in different sectors in Spain, highlighting which ones were more negatively affected by the pandemic after the first COVID-19 wave and which ones created growth and employment during the recovery phase. In this sense, the most negative impacted sectors were culture, tourism and retail while tobacco, pharmaceuticals computer, electronic and optical products sectors pushed the Spanish economy towards recovery. Moreover, the impact of COVID-19 in different aspects such as employment, workers' health, reputation, productivity, among others was also studied. The results reveal that firms invested a lot of time in organising and restructuring work planning to adapt to the new constraints. Finally, based on the findings about the most impacted sectors and the most negatively affected aspects, a set of dimensions and policies are proposed in a roadmap to support the improvement of enterprise resilience capacity to face up to crisis situations such as the one caused by COVID-19.

Indexed as

dimensionsEnterprise resilienceimpactroadmapsectorSpain

Identifiers

PMID38620752
PMCPMC9605712
OpenAlexW4313042695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.